Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 5/20 | 0.53 |
| ▸ | NPY1R | P25929 | 4/20 | 0.53 |
| ▸ | NPY2R | P49146 | 3/20 | 0.53 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.50 |
| ▸ | BACE1 | P56817 | 6/20 | 0.49 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 2/20 | 0.48 |
| ▸ | CTSD | P07339 | 1/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.45 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29531717 | 0.92 | BACE1 (0.56) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL31256990 | 0.91 | OPRD1 (0.55) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL31688175 | 0.91 | ACE (0.53) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL29596043 | 0.89 | BACE1 (0.52) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL30843968 | 0.88 | NPY4R (0.44) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL30799525 | 0.87 | BACE1 (0.58) | BACE1BACE2CTSD | |
| SCHEMBL2184740 | 0.87 | NPY4R (0.66) | NPY4RNPY1RNPY2ROPRD1BACE1 | |
| SCHEMBL31684378 | 0.86 | OPRD1 (0.51) | NPY4RNPY1RNPY2ROPRD1OPRM1 | |
| SCHEMBL5970156 | 0.86 | NAALAD2 (0.56) | NPY4RNPY1RNPY2RENPEP | |
| SCHEMBL159465 | 0.86 | NAALAD2 (0.56) | NPY4RNPY1RNPY2RENPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339504-A1 | CANCER VACCINE WITH USE OF COMMON CANCER ANTIGEN COCKTAIL, TCR/CAR-T CELL THERAPEUTIC, COMPANION DIAGNOSTIC METHOD, AND METHOD FOR DIAGNOSING RISK OF CANCER ONSET BY DETECTING CIRCULATING TUMOR CELLS | NATIONAL CANCER CENTER (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-3368561-B1 | PREVENTION OF N-TERMINAL TRUNCATION IN IGG LIGHT CHAINS | MEDIMMUNE LTD (GB) | 2025-09-17 | — | — | EP | disclosed |